CETP Inhibition Improves HDL Function but Leads to Fatty Liver and Insulin Resistance in CETP-Expressing Transgenic Mice on a High-Fat Diet.

MLA

Zhu, Lin, et al. “CETP Inhibition Improves HDL Function but Leads to Fatty Liver and Insulin Resistance in CETP-Expressing Transgenic Mice on a High-Fat Diet.” Diabetes, vol. 67, no. 12, Dec. 2018, pp. 2494–506. EBSCOhost, https://doi.org/10.2337/db18-0474.

APA

Zhu, L., Luu, T., Emfinger, C. H., Parks, B. A., Shi, J., Trefts, E., Zeng, F., Kuklenyik, Z., Harris, R. C., Wasserman, D. H., Fazio, S., & Stafford, J. M. (2018). CETP Inhibition Improves HDL Function but Leads to Fatty Liver and Insulin Resistance in CETP-Expressing Transgenic Mice on a High-Fat Diet. Diabetes, 67(12), 2494–2506. https://doi.org/10.2337/db18-0474

Chicago

Zhu, Lin, Thao Luu, Christopher H Emfinger, Bryan A Parks, Jeanne Shi, Elijah Trefts, Fenghua Zeng, et al. 2018. “CETP Inhibition Improves HDL Function but Leads to Fatty Liver and Insulin Resistance in CETP-Expressing Transgenic Mice on a High-Fat Diet.” Diabetes 67 (12): 2494–2506. doi:10.2337/db18-0474.